Professional Documents
Culture Documents
Guia de Dolor Lumbar de Minnesota
Guia de Dolor Lumbar de Minnesota
Health System
Guidelines for
Clinical Care
Anthony Chiodo, MD
Physical Medicine &
Rehabilitation
Team members
David Alvarez, DO
Family Medicine
Gregory Graziano, MD
Orthopedic Surgery
dangerous, but uncommon lesions. (3) Utilize diagnostic tests efficiently. (4) Initiate treatment and
refer when appropriate.
Key points:
Andrew Haig, MD
Physical Medicine &
Rehabilitation
Van Harrison, PhD
Medical Education
John McGillicuddy, MD
Neurosurgery
Connie Standiford, MD
General Internal Medicine
Amy Tremper, MD
Obstetrics and Gynecology
Updated
April 2003
with revision
April 2005
UMHS Guidelines
Oversight Team
Connie Standiford, MD
Lee Green, MD, MPH
Van Harrison, PhD
Literature Search Service
Taubman Medical Library
Natural history. Low back pain occurs in about 80% of people [evidence C*]. Within 6 weeks 90%
of episodes will resolve satisfactorily regardless of treatment [C*]. Of all persons disabled for more
than 1 year, 90% will never work again without intense intervention [C*].
Initial visit.
Assess for red flags of serious disease, as well as psychological and social risks for chronic
disability. Diagnostic tests are usually unnecessary [C*]
Treatment options include: ice [D*], NSAIDs [A*], and return to usual activities - bed rest is not
recommended [A*]. (COX-2 inhibitors are no more effective than traditional NSAID agents and
should be reserved for carefully selected patients. [A])
Close clinical follow up until return to work or key life activities [D*].
By 2 weeks (acute). If work disability persists, consider physiatric consultation [A*] especially is
psychosocial risks to return to work exist.
For radicular pain, by 2-4 weeks: If no improvement obtain MRI [B*]. If not diagnostic, obtain
EMG. If pathology proven, consider acute physiatrist or anesthesiology pain specialist evaluation
(for injection therapy) or surgical evaluation [A*]. If pathology not proven, consider physiatrist or
anesthesiology pain specialist referral [D*].
By 6 weeks (subacute). If activities are still limited, consider anesthesiology pain specialist or
physiatric consultation regarding a complex rehabilitation program [A*].
By 12 weeks (chronic). If still disabled from major life activities or work, strongly consider referral
to an anesthesiology pain specialist or physiatrist for a complex rehabilitation team [A*].
Clinical Background
For more information call
GUIDES: 936-9771
Regents of the
University of Michigan
These guidelines should not be
construed as including all proper
methods of care or excluding other
acceptable methods of care reasonably
directed to obtaining the same results.
The ultimate judgment regarding any
specific clinical procedure or treatment
must be made by the physician in light of
the circumstances presented by the
patient.
Clinical Background
Definitions
Low back pain (LBP) is posterior trunk pain
between the ribcage and the gluteal folds. It
also includes lower extremity pain that results
from low back disorder (sciatica/radiating low
back pain), whether there is trunk pain or not.
Sciatica is radiating, lower extremity pain and
may not be associated with back pain. Sciatica
should be clearly distinguished from axial low
back pain.
Acute LBP: Back pain <6 weeks duration
Subacute LBP: Back pain >6 weeks but
<3 months duration
Chronic LBP: Back pain disabling the
patient from some life activity >3 months
1
Epidemiology
The one-year point prevalence of low back problems
in the U.S. population is 15-20%. Eighty percent of
the population will experience at least one episode of
disabling low back pain during their lifetime.
Approximately 40% of persons initially seek help
from a primary care physician, 40% from a
chiropractor, and 20% from a subspecialist.
(Continued on page 7)
Yes
No
Spinal fracture
or compressions
Is pain radiating?
No
Yes
Go to
"Non-Radiating
Pain", Table 3
No
Evidence of serious
disease? (Table 1)
No
Yes
Infection
X
X
X
X
X
X
X
X
Yes
Is pain radiating?
* Levels of Evidence:
A = randomized controlled trials
B = controlled trials, no randomization
C = observational trials
D = opinion of expert panel
Go to
"Radiating Pain",
Table 4
X
X
X
X
X
X
X
X
X
Aortic aneurysm
Aortic atherosclerosis
Renal infection
Renal calculi
Peritonitis
Tumors
Subacute bacterial endocarditis
Metabolic disorders:
Porphyria
sickle cell disease
renal osteodystrophy
Seronegative spondylitic arthritis:
Ankylosing spondylitis
Reiter's syndrome
Arthritis of ulcerative colitis
Psoriatic arthritis
Other arthritis:
Diffuse Idiopathic Skeletal
Hyperostosis (DISH)
Scheuermann's epiphisitis
Rheumatoid arthritis--uncommon
Connective tissue disorders:
Marfan's syndrome
Ehlers-Danlos syndrome
Myopathy
Inflammatory radiculopathy AIDP/CIDP
Spinal
Cord Level
S-1
Dorsi flexion
L-5
Plantar flexion
Dorsi flexion
S-1a
L-4, L-5
Knee
Extension
Flexion
L-3,4
L-5, S-1
Hip
Flexion
Abduction
L-2, 3
L-5, S-1
L-5, S-1b
Location
Toe
Ankle
Internal Rotation
Adduction
a
b
c
Achilles
Spinal Cord
Level
S-1
Medial Hamstringc
Patella
L-5
L-4
Babinski
Tests upper
motor
neurons
Reflex Tests
L-3, 4
Ankle plantar flexion--rise up on the toes of one leg 5 times while standing.
Internal rotation--while seated patient keeps knees together and ankles apart, examiner attempts to push ankles together.
While the patient is seated the examiner palpates the medial hamstring tendon and sharply percusses his/her hand. Contraction
of the hamstring muscle is palpated.
Initial Visit
Subsequent Visits
History and Physical: Update history and physical. If
diagnostic impression changed, go to appropriate steps in
Figure 1.
Activity Limitations:
Bed rest. Avoid bed rest [A*].
Work restrictions. Patients should not commonly be
restricted from work [D*].
General activity. Resume usual activities. Sometimes it
is reasonable to restrict a person from long distance
driving, heavy lifting, sitting for prolonged periods, or
repetitive twisting and reaching [D*].
General Treatment:
If pain better: Reduce medications, increase activity.
If pain worse: Consider changing/adding medications,
increasing restrictions.
Physical therapy. If no improvement, at 1-2 weeks [A*]
consider manual physical therapy (spinal manipulation).
If at Risk: Chronic Disability Prevention (Table 2)
Patient education [A*]
Minimize restrictions
At 6 weeks consider referral to spine rehab program
Initial Visit
Subsequent Visits
History and Physical: Update history and physical. If
diagnostic impression is changed, go to appropriate steps in
Figure 1.
If pain better: Reduce medications, increase activity [D*].
If no improvement:
At 1-2 weeks [D*] consider physical therapy McKenzie
exercises [A*].
At 2-4 weeks obtain MRI [B*]. If MRI is not diagnostic,
obtain EMG [B*]. (Plain X-rays are usually not helpful.)
- If pathology proven by MRI/EMG: consider acute
physiatric or pain specialist evaluation (for injection
therapy) or surgical evaluation [A*].
- If pathology not proven by MRI/EMG: consider
physiatrist referral [D*].
If at Risk: Chronic Disability Prevention (Table 2)
Patient education: See relevant information under initial
visit above.
Minimize restrictions
At 6 weeks consider referral to spine rehab program.
Follow-Up (in patient at risk for chronic disability)
If kept out of work: See in 23 days, then weekly.
If moderate pain/some restrictions: See patient weekly.
At 6 weeks and disabled [A*]: Consider referral to spine
specialist -- leg pain to surgeon, back pain or psychosocial
issues to physiatrist.
At 12 weeks and disabled [B*]: Consult spine
rehabilitation program. Consider surgical consultation.
[D*].
NSAID
Brand Name
Typical Oral
Dose (mg)
Cost/Month ($)
Generic
600 QID or
800 TID
600 TID
100 TID
75 TID
500 BID
1200 QAM
19
19
81
180
NA
94
110
9
11
19
47
33
12
31
Aseptic meningitis
Tinnitus
Lower GI effect/renal
risk
Lower GI effect/renal
risk
Ibuprofen
Motrin
Fenoprofen
Flurbiprofen
Ketoprofen
Naproxen
Oxaprozin
Nalfon
Ansaid
Orudis
Naprosyn
Daypro
Aspirin
Salsalate
Multiple
Disalcid
975 TID
1500 BID
15
87
7
10
Choline
magnesium
trisalicylate
Diflunisal
Trilisate, Tricosal
1500 BID
140
56
500 BID
80
51
Diclofenac
Voltaren, Arthrotec
Cataflam
Etodolac
Indomethacin
Lodine
Indocin
300 BID
50 TID
92
89
34
14
Sulindac
Tolmetin
Ketorolac
Clinoril
Tolectin
Toradol, Acular
200 BID
400 TID
10 QID
81
122
119
27
83
80
Enolic Acids
Phenylbutazone
Piroxicam
Meloxicam
N.A.
Feldene
Mobic
100 TID
20 daily
7.5-15 daily
NA
86
63 - 70
NA
5
NA
Fenamic Acids
Naphthylkanones
Meclofenamate
Nabumetone
Meclofenamate
Relafen
50 QID
1000 daily
NA
81
30
56
Muscle
Relaxants
Cyclobenzaprine
Carisprodol
Baclofen
Diazepam
Flexeril
Soma
Lioresal
Valium
10 TID
350 QID
10 QID
10 QHS
103
400
NA
48
11
26
33
4
COX-2 Inhibitor
(See Table 8)
Celecoxib
Celebrex
200 daily
74
NA
Proprionic Acids
Carbolic Acids
Acetic Acids
Side Effects
Brand
Dolobid
75 BID
50 TID-QID
108
135-180
16
42-54
Lower GI effect/renal
risk
Worse risk for liver
disease
Low GI effect
Risk of headaches
Avoid in renal disease
Better for renal disease
Liver disease
For brand drugs, Average Wholesale Price minus 10%. AWP from Amerisource Bergen Wholesale Catalog 10/02. For generic drugs,
Maximum Allowable Cost plus $3 from BCBS of Michigan MAC List, 1/15/03. Those generic drugs where MAC is not established, cost is
based upon double the Wholesale Acquisition Cost (WAC) from the Amerisource Bergen Wholesale Catalog 10/02 plus $3.
Financial Impact
The personal, social, and financial effects of back pain are
substantial. In America the direct annual cost is 40 billion
dollars, with indirect costs--lost wages and productivity,
legal and insurance overhead, and impact on family--at over
100 billion dollars. Important acute care costs result from
over utilization of diagnostic and treatment modalities, and
inappropriate activity restrictions. The small number of
persons who become chronically disabled consume 80% of
the cost.
History.
questions:
treatments?
The examination also includes Gordon Waddel's five "nonorganic pain" signs. If 3 or more of these 5 "Waddel" signs
are present, then it is likely that there is a psychogenic
component to the patients pain behavior.
Treatment
Special Circumstances
Primary Prevention
Controversial Areas
Disclosures
The University of Michigan Health System endorses the
Guidelines of the Association of American Medical
Colleges and the Standards of the Accreditation Council for
Continuing Medical Education that the individuals who
present educational activities disclose significant
relationships with commercial companies whose products
or services are discussed. Disclosure of a relationship is not
intended to suggest bias in the information presented, but is
made to provide readers with information that might be of
potential importance to their evaluation of the information
The important educational points for patients with nonradiating and with radiating pain are listed in Tables 5 and 6
respectively.
Providing good educational handouts is also important.
One study demonstrated that providing a more detailed
booklet produced a better result than providing a simple
information sheet.
Company
(none)
(none)
(none)
Relationship
Rehabilitation Team
Assessments, LLC
president
(none)
(none)
(none)
(none)